Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Peter Saltonstall, president and CEO of the National Organization for Rare Disorders (NORD), about the 40th anniversary of the landmark Orphan Drug Act.

Read the full story here: At 40, Orphan Drug Act Enjoys Rare Bipartisan Support